CU Startup News
ColdQuanta CEO Scott Faris was featured on the "Innovating with Scott Amyx" podcast to talk about the future of the CU Boulder-founded business and commercialization within academia.
Chemical & Engineering News (C&EN) identified young scientists who are trying to solve formidable global problems. Lim was recognized for developing organic molecules that spur on light-powered reactions.
CU Boulder startup ColdQuanta, JILA physicists, and other university innovators are featured in a new film from the babyÖ±²¥app Office of Economic Development and International Trade (OEDIT) promoting babyÖ±²¥app's extensive quantum ecosystem.
Respirogen, a company whose research is led by Biomedical Engineering Program Director Mark Borden and founded by Borden’s former student, Paul Mountford (PhDMechEngr’15), has developed microbubbles that can deliver oxygen to the blood stream independent of the lungs.
Co-founded by CU Boulder professor Mike McGehee, Tynt has raised $8.5 million in seed funding to scale its reversible metal electrodeposition (RME) technology, which is used to create blackout windows that aim to increase home comfort, privacy and energy efficiency.
Otoro Energy, spun out of technology developed in Assistant Professor Michael Marshak's lab at CU Boulder, has received $4.14M from the U.S. Department of Energy to improve the cost, scalability and performance of existing flow battery technology through a metal chelate flow battery system.
The Louisville-based CU Boulder startup company is moving into a 75,000-square-foot building in Thornton. The expansion comes as the company prepares to go public. In June, Solid Power announced a merger valued at $1.2B with Decarbonization Plus Acquisition Corp. III.
Meati Foods is a CU spinout company hoping that fungi, not plants, could be key to winning the protein wars and confronting climate change. Co-founders Tyler Huggins and Justin Whiteley met as Ph.D. students at CU Boulder, where Whiteley studied material science and Huggins studied environmental engineering.
Xalud Therapeutics is a clinical-stage biotechnology company developing therapies initially worked on and developed at CU Boulder for the treatment of neuro-inflammatory diseases and inflammatory joint disorders, including osteoarthritis and rheumatoid arthritis.
Aspero Medical Inc. received a U.S. patent for technology related to its planned medical device, a new balloon catheter for use in gastrointestinal endoscopies. The patent means Aspero can seek FDA approval this year and with commercialization to follow in early 2022 if successful. Aspero CEO Mark Rentschler invented the technology with Steven Edmundowicz and Karl Johannes. Rentschler and Edmundowicz are CU Boulder professors; Johannes was one of Rentschler’s PhD students.